5-BROMO-4-CHLORO-7-(TRIISOPROPYLSILYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95%, 1g

Methyl 2-(4-aminocyclohexyl)acetate, 95+%, 500mg

Tert-butyl3-ethynylazepane-1-carboxylate, 98%, 1g

1,4-Bis[2-(5-fenilossazolil)]benzene min 99% per scintillazione 100g

2-[(Carboxymethyl-methyl-amino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

N-Acetyl-DL-2-phenylglycine>98.0%(HPLC)(T)25g

9,10-Dibromophenanthrene, 95.0%, 250mg

(6-((tert-Butoxycarbonyl)amino)pyridin-3-yl)boronic acid, 95.0%, 10g

Soluzione di modificatore di matrice di nitrato di magnesio, 20 g/L Mg(NO3)2 (99,999%) in H2O, 50 mL

5-(Trifluoromethyl)isobenzofuran-1,3-dione, 95.0%, 100mg

4-Bromobenzo[d]oxazol-2(3H)-one, 98%, 1g

tert-butyl 3-bromo-3-(hydroxymethyl)azetidine-1-carboxylate, 95.0%, 1g

2-Bromo-5-chloropyrazolo[1,5-a]pyrimidine, 97%, 5g